Development of drug delivery systems for the dermal application of therapeutic DNAzymes.

DNAzymes are potent novel drugs for the treatment of inflammatory diseases such as atopic dermatitis. DNAzymes represent a novel class of pharmaceuticals that fulfil a causal therapy by interruption of the inflammation cascade at its origin. There are two challenges regarding the dermal application of DNAzymes: the large molecular weight and the sensitivity to DNases as part of the natural skin flora. To overcome these limitations suitable carrier systems have to be considered. Nano-sized drug carrier systems (submicron emulsions, microemulsions) are known to improve the skin uptake of drugs due to their ability to interact with the skin's lipids. To protect the drug against degradation, the hydrophilic drug may be incorporated into the inner aqueous phase of carrier systems, such as water-in-oil-in-water multiple emulsions. In the present study various emulsions of pharmaceutical grade were produced. Their physicochemical properties were determined and the influence of preservation systems on stability was tested. Drug release and skin uptake studies using various skin conditions and experimental set-ups were conducted. Furthermore, cellular uptake was determined by flow cytometric analysis. The investigations revealed that the developed multiple emulsion is a suitable and promising drug carrier system for the topical application of DNAzyme.

[1]  J. Grossiord,et al.  Vehicle influence on in vitro release of metronidazole: role of w/o/w multiple emulsion , 1994 .

[2]  Jacek Szymanski,et al.  Structural Rearrangements of the 10–23 DNAzyme to β3 Integrin Subunit mRNA Induced by Cations and Their Relations to the Catalytic Activity* , 2003, Journal of Biological Chemistry.

[3]  E. Perrier,et al.  Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. , 2004, International journal of pharmaceutics.

[4]  A. Fullerton,et al.  Development of an in vitro Skin Permeation Model Simulating Atopic Dermatitis Skin for the Evaluation of Dermatological Products , 2007, Skin Pharmacology and Physiology.

[5]  R. Egan,et al.  T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice. , 1995, Clinical immunology and immunopathology.

[6]  S. Silverman.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA , 2005, Nucleic acids research.

[7]  S. Bloomfield,et al.  The effect of co-solvents on the antibacterial activity of paraben preservatives , 1995 .

[8]  D. Friedman,et al.  Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs. , 1995, Journal of pharmaceutical sciences.

[9]  E. Maggi.  The TH1/TH2 paradigm in allergy. , 1998, Immunotechnology : an international journal of immunological engineering.

[10]  A. Florence,et al.  Some features of breakdown in water-in-oil-in-water multiple emulsions , 1981 .

[11]  S. Fukushima,et al.  Preparation of and drug release from W/O/W type double emulsions containing anticancer agents using an oily lymphographic agent as an oil phase. , 1987, Chemical & pharmaceutical bulletin.

[12]  Ljiljana Djekic,et al.  The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. , 2008, International journal of pharmaceutics.

[13]  José Blanco-Méndez,et al.  Delivery of a hydrophilic solute through the skin from novel microemulsion systems , 1997 .

[14]  Peggy Schlupp,et al.  Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme. , 2011, International journal of pharmaceutics.

[15]  L. Zon,et al.  Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription , 1993 .

[16]  D. Leung,et al.  Atopic dermatitis: new insights and opportunities for therapeutic intervention. , 2000, The Journal of allergy and clinical immunology.

[17]  L. Bromberg,et al.  Optimization of a thermally reversible W/O/W multiple emulsion for shear-induced drug release. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[18]  W. Steiling,et al.  Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  W. Paul,et al.  GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors , 2006, Cell Research.

[20]  W. Ahn,et al.  Topical delivery of interleukin‐13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis , 2009, The journal of gene medicine.

[21]  A. Florence,et al.  The formulation and stability of multiple emulsions , 1982 .

[22]  W. Henke,et al.  Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. , 2008, The Journal of allergy and clinical immunology.

[23]  Russell O. Potts,et al.  Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids , 1991, Pharmaceutical Research.

[24]  Mads Kreilgaard,et al.  Influence of microemulsions on cutaneous drug delivery. , 2002, Advanced drug delivery reviews.

[25]  A. Masuda,et al.  The Interaction between GATA Proteins and Activator Protein-1 Promotes the Transcription of IL-13 in Mast Cells1 , 2004, The Journal of Immunology.

[26]  A. Fahr,et al.  Particle size of liposomes influences dermal delivery of substances into skin. , 2003, International journal of pharmaceutics.

[27]  D. Dobler,et al.  Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: effect of additives on emulsion stability. , 2010, International journal of pharmaceutics.

[28]  G. Barratt,et al.  Formulation of shear rate sensitive multiple emulsions. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[29]  R. Neubert,et al.  Modification of drug penetration into human skin using microemulsions , 1997 .

[30]  Mandip Singh,et al.  Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. , 2002, International journal of pharmaceutics.

[31]  P. Barnes,et al.  Role of GATA-3 in allergic diseases. , 2008, Current molecular medicine.

[32]  D B Corry,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[33]  D. Leung,et al.  Cellular and immunologic mechanisms in atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[34]  D. Friedman,et al.  Enhanced Transdermal Delivery of Diazepam by Submicron Emulsion (SME) Creams , 1995, Pharmaceutical Research.

[35]  Y. Shibata,et al.  Ragweed-induced expression of GATA-3, IL-4, and IL-5 by eosinophils in the lungs of allergic C57BL/6J mice. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[36]  S R KOHN,et al.  EFFECTIVENESS OF ANTIBACTERIAL AGENTS PRESENTLY EMPLOYED IN OPHTHALMIC PREPARATIONS AS PRESERVATIVES AGAINST PSEUDOMONAS AERUGINOSA. , 1963, Journal of pharmaceutical sciences.

[37]  J. Grossiord,et al.  A topical W/O/W multiple emulsion containing several active substances : formulation, characterization and study of release , 1993 .

[38]  Wong,et al.  Biological barriers to cellular delivery of lipid-based DNA carriers. , 1999, Advanced drug delivery reviews.

[39]  Y. Kita,et al.  An attempt at preparing water-in-oil-in-water multiple-phase emulsions , 1976 .

[40]  J. Double,et al.  The delivery of antisense therapeutics. , 2000, Advanced drug delivery reviews.

[41]  J. Robbins,et al.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article. , 2005, Gene therapy & molecular biology.

[42]  G. F. Joyce,et al.  Mechanism and utility of an RNA-cleaving DNA enzyme. , 1998, Biochemistry.

[43]  B. Müller,et al.  W/O/W multiple emulsions with diclofenac sodium. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.